HomeACADEMIA
ACADEMIA

MHLW Study Group to Discuss Roles of JAK Inhibitors and Biosimilars toward RA Treatment Guidelines Revision
(Jun.5.2018)

A study group of the Ministry of Health, Labor and Welfare (MHLW) will embark on a study toward the next revision of the Japan College of Rheumatology’s (JCR) guidelines for the treatment of rheumatoid arthritis (RA), focusing on the use of JAK inhibitors and biosimilars. The revision is expected in FY2020 ...
(LOG IN FOR FULL STORY)